Biofarma Of Turkey Said For Sale For Up To $1 Billion By Investor Owners
This article was originally published in PharmAsia News
Executive Summary
Turkey's Biofarma Pharmaceutical Industry could be up for sale, which could make the deal the nation's biggest in the healthcare field